42,838 Shares in Aveanna Healthcare Holdings Inc. $AVAH Acquired by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 42,838 shares of the company’s stock, valued at approximately $367,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd lifted its position in shares of Aveanna Healthcare by 252.4% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after acquiring an additional 2,400 shares during the period. Quantbot Technologies LP bought a new position in shares of Aveanna Healthcare in the second quarter worth $43,000. Summit Securities Group LLC bought a new position in shares of Aveanna Healthcare in the first quarter worth $53,000. Oxford Asset Management LLP acquired a new position in Aveanna Healthcare in the second quarter valued at about $64,000. Finally, C M Bidwell & Associates Ltd. bought a new stake in Aveanna Healthcare during the second quarter worth about $69,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 14,500,002 shares of the business’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $166,750,023.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the company’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $143,704,885.50. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 59,904,505 shares of company stock worth $649,301,514 in the last three months. 5.30% of the stock is owned by corporate insiders.

Aveanna Healthcare Stock Performance

Aveanna Healthcare stock opened at $13.58 on Tuesday. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. The stock has a market cap of $2.96 billion, a PE ratio of 11.04, a P/E/G ratio of 0.85 and a beta of 1.97. Aveanna Healthcare Holdings Inc. has a 12-month low of $5.93 and a 12-month high of $14.00. The business’s 50-day moving average price is $10.79 and its two-hundred day moving average price is $8.35.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The firm had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million. As a group, analysts expect that Aveanna Healthcare Holdings Inc. will post 0.75 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on AVAH. UBS Group increased their price objective on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday, August 14th. BMO Capital Markets boosted their target price on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Royal Bank Of Canada upped their price target on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a report on Monday, August 24th. Barclays increased their price target on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the stock an “overweight” rating in a research report on Friday, August 28th. Finally, Wall Street Zen downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, Aveanna Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $13.50.

Aveanna Healthcare Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.